Pharmaceuticals

MetaCell launches innovative Cloud Hosting for life science and healthcare

CAMBRIDGE, Mass., Sept. 29, 2021 /PRNewswire/ -- MetaCell, an innovative life science software company specialized in creating cutting-edge research software for major pharma, biotech, and academic institutions, has launchedMetaCell Cloud Hosting

2021-09-29 07:54 2897

EW Nutrition launches Pretect D to support poultry gut health during challenging periods

VISBEK, Germany, Sept. 29, 2021 /PRNewswire/ -- EW Nutrition announces the launch of a novel gut health solution for poultry. Pretect D, a proprietary blend of phytomolecules, helps maintain bird performance and farm profitability. Trials indicate that Pretect D offers natural support even during...

2021-09-29 07:40 1636

Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

DURHAM, N.C. and BEIJING, Sept. 28, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2021-09-28 08:00 6175

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

* Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in theAtlanta, GA, United States * AIOS is the MDx system that integrates Seegene's liquid handler and real-time PCR instruments. * Seegene MDx system will efficiently access a wide ...

2021-09-27 19:02 3454

Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis

STOCKHOLM, Sept. 27, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that the company's Phase III clinical study of its drug candidate AKP02 for the treatment of psoriasis has been approved by the Indian Medical Products Agency and is ready to start...

2021-09-27 17:37 2099

Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting

SAN FRANCISCO and SUZHOU, China, Sept. 27, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2021-09-27 08:00 4712
1 ... 180181182183184

Week's Top Stories